Skip Navigation



Rheumatology Advance Access published online on February 10, 2005

Rheumatology, doi:10.1093/rheumatology/keh558
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/5/602    most recent
keh558v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wong, C. K.
Right arrow Articles by Lam, C. W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, C. K.
Right arrow Articles by Lam, C. W. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Society for Rheumatology; all rights reserved
Received November 9, 2004
Accepted December 24, 2004

Original Papers

Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus

C. K. Wong 1, L. C. W. Lit 1, L. S. Tam 2, E. K. Li 2, and C. W. K. Lam 1*

1 Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
2 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

* To whom correspondence should be addressed.
C. W. K. Lam, E-mail: waikeilam{at}cuhk.edu.hk


   Abstract

Background. Osteopontin (OPN) is an extracellular matrix cell adhesion phosphoprotein with immunological activities including stimulation of macrophage chemotaxis, T-helper type 1 lymphocyte response and B-cell antibody synthesis. Overexpression of OPN has been associated with the development of the autoimmune/lymphoproliferative syndrome.

Methods. We measured the plasma concentration and ex vivo production of OPN, and the plasma proinflammatory IL-18 concentration in 54 SLE patients with or without renal impairment (RSLE group and SLE group, respectively) and 26 sex- and age-matched control (NC) subjects using an enzyme-linked immunoabsorbent assay.

Results. Plasma OPN concentrations were significantly higher in RSLE and SLE patients than in the NC group (both P<0.001). Increase in OPN concentration correlated positively and significantly with SLEDAI score in all SLE patients (r = 0.308, P = 0.023). The ex vivo production of OPN upon mitogen activation of peripheral blood mononuclear cells was significantly higher in the RSLE and SLE groups than in the NC group (both P<0.001). In RSLE patients, plasma OPN concentration showed a significant positive correlation with proinflammatory cytokine IL-18 concentration (r = 0.404, P = 0.037).

Conclusion. The above results suggest that the production of OPN is associated with the inflammatory process and SLE development, and may serve as a potential disease marker of SLE.

Keywords: SLE; Osteopontin; IL-18; SLEDAI.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Murugaiyan, A. Mittal, and H. L. Weiner
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
J. Immunol., December 1, 2008; 181(11): 7480 - 7488.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. K. Tso, W.-N. Huang, H.-Y. Huang, and C.-K. Chang
Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus
Rheumatology, September 1, 2006; 45(9): 1148 - 1153.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
T K Tso, W-N Huang, H-Y Huang, and C-K Chang
Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus
Lupus, April 1, 2006; 15(4): 207 - 212.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.